Why Your Saliva Is the Most Underrated Tool for Healthy Teeth

Saliva performs five core protective functions simultaneously: acid buffering, enamel mineral delivery, protective pellicle formation, antibacterial defense, and mechanical clearance. All five degrade at once when salivary flow drops. Xerostomia affects at least 20% of adults, up to 50% of those over 65, and is a side effect of more than 500 medications including antidepressants, antihistamines, antihypertensives, and GLP-1 agonists. Modern eating patterns, polypharmacy, and mouth breathing are reducing saliva at population scale. Chewing sugar-free gum is the first-line ADA-recommended intervention and the most accessible way to restore the masticatory salivary stimulus.


22 min read

Why Your Saliva Is the Most Underrated Tool for Healthy Teeth

Quick Answer

Saliva is the oral cavity's primary defense system, operating continuously whether you're thinking about it or not. It does five things nothing else in your oral care routine can replicate: buffers acid through a bicarbonate system that neutralizes post-meal pH drops, maintains enamel mineral supersaturation so the conditions for remineralization are always present, forms a protective protein pellicle on enamel that limits acid penetration, delivers immunoglobulins and antibacterial enzymes that suppress cariogenic bacteria, and physically clears food debris and bacteria from tooth surfaces. All five of these happen at adequate salivary flow. When flow drops, all five degrade simultaneously. Xerostomia (dry mouth) affects at least 20% of the general adult population, up to 50% of adults over 65, and is a side effect of more than 500 medications including antidepressants, antihistamines, antihypertensives, GLP-1 agonists, and diuretics. Modern life has created more routes to inadequate saliva than at any previous point in history. Stimulating saliva through chewing is the most accessible and most immediate way to restore it.

Last updated: July 2026 | Reviewed against saliva composition and function literature, xerostomia epidemiology, ADA dry mouth guidance, and medication-induced salivary dysfunction research

When people think about protecting their teeth, they think about brushing, flossing, and fluoride. Saliva rarely comes up, despite being the only protective system operating in your mouth 24 hours a day without any active input from you. Your toothbrush contacts your teeth twice a day for two minutes. Your saliva contacts them continuously. Understanding what it does during that continuous contact, and what happens when there isn't enough of it, changes the way you think about the whole oral health equation.

What Saliva Actually Is (It's More Than Water)

Saliva is approximately 99% to 99.5% water. That remaining 0.5% to 1% is responsible for virtually everything that makes saliva biologically important. It contains electrolytes (calcium, phosphate, bicarbonate, sodium, potassium, fluoride), proteins (including statherin, proline-rich proteins, mucins, histatins, and cystatins), immunoglobulins (secretory IgA, IgG, IgM), enzymes (amylase, peroxidase, lysozyme), and antimicrobial peptides. Each of these components plays a specific role in the oral health system, and the list is not redundant: remove any one and something measurable changes in the mouth.

Adults produce between 0.5 and 1.5 liters of saliva per day. Resting (unstimulated) flow rate is approximately 0.3 to 0.4 mL per minute. Stimulated flow (from eating, chewing, or tasting) rises to 1.5 to 2.0 mL per minute and can reach 3 to 4 mL per minute with active chewing. Salivary flow follows a circadian rhythm: it peaks in the early afternoon and reaches its lowest point at night, which is why overnight is the highest-risk period for tooth demineralization and why the morning oral environment after a night of reduced flow is more acid-vulnerable than the afternoon.

Three salivary glands produce the bulk of saliva: the parotid glands (which produce thin, serous saliva rich in amylase), the submandibular glands (which produce most of the resting saliva and mix serous and mucous types), and the sublingual glands (which produce primarily mucous saliva). Hundreds of minor salivary glands distributed throughout the oral mucosa contribute additional secretion. The composition of saliva changes depending on which gland is most active, the stimulation state, and the time of day.

The Five Core Functions of Saliva for Enamel Health

Saliva's role in oral health is sometimes described simply as "keeping the mouth moist." The actual function set is considerably more specific and more mechanistically important than that description implies. There are five discrete mechanisms through which saliva protects teeth, each operating through a different biological pathway.

Function 1: Acid Buffering

Every time bacteria in dental plaque ferment dietary carbohydrates, they produce lactic acid. This drops the pH in the plaque biofilm below 5.5, the critical threshold at which enamel hydroxyapatite begins to dissolve. The speed at which pH recovers above 5.5 after this challenge determines how long enamel spends in a demineralizing state per meal.

Saliva has three buffer systems that work to neutralize this acid. The most important, operating primarily in stimulated saliva, is the bicarbonate/carbonate system: bicarbonate ions in saliva combine with hydrogen ions from lactic acid to form carbonic acid, which rapidly dissociates into water and carbon dioxide, removing the acid. The phosphate buffer system is more active in resting (unstimulated) saliva. The protein buffer system (proteins accepting hydrogen ions directly) contributes a third layer of acid resistance.

The result, when salivary flow is adequate, is the Stephan curve recovery: pH drops sharply within two to three minutes of eating, then recovers above 5.5 within 20 to 40 minutes as saliva buffers the acid. When flow is inadequate, the recovery is slower and the time spent below pH 5.5 per meal is longer. For people with severe xerostomia, the recovery may be partial: pH may not return to fully safe levels between meals at all, leaving enamel in near-constant partial demineralization.

Saliva maintains oral pH in a range of approximately 6.8 to 7.8 in a healthy oral environment (Novel Impacts of Saliva, PMC). This is the operating range within which enamel remineralization can proceed. Outside of it, the equilibrium tips toward demineralization regardless of what else is present.

The Five Core Functions of Saliva for Enamel Health Saliva's Five Protective Functions Sources: PMC Novel Impacts of Saliva 2021; J Prosthet Dent 2001; Frontiers Oral Health 2025; NIDCR; IntechOpen 1. Acid Buffering Bicarbonate neutralizes post-meal acid 2. Mineral Delivery Ca²⁺ + PO₄ supersaturation remineralizes enamel 3. Protective Pellicle Protein film on enamel limits acid penetration 4. Antibacterial Defense IgA, peroxidase, histatins suppress cariogenic bacteria 5. Mechanical Clearance Physical removal of food debris and bacteria When salivary flow drops, ALL FIVE degrade simultaneously Xerostomia: at least 20% of adults; up to 50% of adults 65+; side effect of 500+ medications Sources: CDHO; ADA Xerostomia guidance; StatPearls NCBI

Function 2: Mineral Delivery and Enamel Supersaturation

Enamel remineralization requires two things: a pH above 5.5 (provided by saliva's buffering function) and a supply of calcium and phosphate ions (provided by saliva's mineral content). Both conditions must be present simultaneously. Saliva provides both.

Healthy saliva is supersaturated with calcium and phosphate relative to enamel hydroxyapatite. This means the concentration of these ions in saliva is higher than what's needed to maintain the mineral in enamel, creating a thermodynamic gradient that favors mineral deposition rather than dissolution under neutral pH conditions. The salivary protein statherin is specifically responsible for maintaining this supersaturation: it binds calcium and phosphate in a stabilized complex, preventing them from precipitating out of solution as calcium phosphate crystals before they can reach enamel surfaces where they're needed. Without statherin, the calcium and phosphate would crystallize in the saliva itself and the supersaturation would be lost.

A 2024 PMC review (The Remineralization of Enamel from Saliva: A Chemical Perspective) confirmed the central role of this system: saliva naturally remineralizes early erosive lesions from acidic foods and drinks as well as initial carious lesions by depositing calcium phosphate back into the enamel crystal structure. The same review noted that salivary proteins modulate the rate of remineralization to prevent "overshooting" (excessive mineral deposition). Saliva is not just delivering calcium: it is a precisely regulated mineral delivery system.

Function 3: Protective Pellicle Formation

Within minutes of any tooth surface being cleaned, salivary proteins begin adsorbing to the enamel surface and forming a thin organic film called the acquired enamel pellicle (AEP). This film, composed of statherin, histatins, cystatins, proline-rich proteins, and other salivary proteins, serves as a protective barrier between the enamel mineral and the acids, bacteria, and abrasives in the oral environment.

The pellicle's functions are multiple: it inhibits demineralization by limiting acid access to the enamel surface; it serves as a selective interface for bacterial adhesion (some bacteria bind to pellicle proteins to colonize teeth, but the same proteins regulate which species can do so); and it provides a lubrication layer that reduces mechanical wear from food contact and brushing. The pellicle reforms continuously as saliva flows. When salivary flow is severely reduced, the pellicle is thinner, less continuous, and provides less protection. This is part of why xerostomia dramatically accelerates enamel erosion even from acidic foods and drinks that would cause minimal damage in a person with normal salivary flow.

Function 4: Antibacterial Defense

Saliva is a complex antibacterial medium. Secretory immunoglobulin A (sIgA), the most abundant antibody in saliva, binds to bacterial surface proteins and prevents bacteria from adhering to tooth and mucosal surfaces. Salivary peroxidase (sialoperoxidase) catalyzes the conversion of thiocyanate ions and hydrogen peroxide into hypothiocyanate, a potent antibacterial compound. Histatins are small cationic proteins that disrupt bacterial cell membranes and have documented antifungal activity. Lysozyme cleaves bacterial cell wall peptidoglycans. Lactoferrin sequesters iron that bacteria need for growth.

This multilayer antibacterial system collectively suppresses Streptococcus mutans, Lactobacillus, and other cariogenic bacteria without eliminating the commensal bacteria that maintain a balanced oral microbiome. It's a targeted suppression system, not a broad-spectrum antimicrobial one. When salivary flow decreases, the concentrations of all these antimicrobial components decrease, and the balance tips toward dysbiosis: cariogenic bacteria gain relative advantage, acid production increases, and caries risk rises.

Function 5: Mechanical Clearance

Salivary flow physically moves bacteria, food residue, and acid away from tooth surfaces. This clearance function is sometimes called "oral clearance" and refers to the rate at which sugars, acids, and bacteria are diluted and removed from the oral cavity after eating. Higher salivary flow = faster clearance = shorter exposure time per eating occasion.

The relationship between salivary clearance and caries risk is well established: individuals with higher resting and stimulated salivary flow rates show lower caries incidence after controlling for dietary and hygiene variables. Conversely, individuals with impaired salivary flow show dramatically higher caries rates, with xerostomia-induced caries appearing in atypical locations (root surfaces, cervical margins, incisal edges) not typically vulnerable in people with normal saliva.

Why Modern Life Is Reducing Saliva at Scale

All five functions described above depend on adequate salivary flow. The problem is that the modern environment has created multiple converging pressures that reduce salivary flow in a growing proportion of the population. The scale of this is larger than most people realize.

Xerostomia (dry mouth) affects at least 20% of the general adult population, with prevalence rising to up to 30% in women and up to 50% in adults over 65 (CDHO). A 2026 Frontiers in Oral Health register-based study found that in patients taking five or more medications simultaneously (polypharmacy), combined with age over 71, the odds of xerostomia were 9.68 times higher than in the general population. As the US population ages and the average number of medications per adult increases, these numbers will grow.

Medications: The Leading Cause

More than 500 medications list xerostomia as a side effect. This is not a marginal pharmacological footnote: it is the most common cause of reduced salivary flow in the adult population. The ADA's Xerostomia guidance lists the major categories: antihistamines (allergy and asthma medications), antihypertensive medications, decongestants, pain medications, diuretics, muscle relaxants, GLP-1 receptor agonists, and antidepressants.

The mechanism for most of these is anticholinergic activity: they block acetylcholine from binding to muscarinic receptors in the salivary glands, reducing the parasympathetic nervous system signal that drives salivary secretion. A 2025 European Psychiatry study on psychiatric medication-induced xerostomia found prevalence rates of 30 to 50% for amitriptyline (a tricyclic antidepressant), 20 to 40% for paroxetine (an SSRI), and 20 to 65% for anticholinergic agents. Sugar-free chewing gum was specifically cited as a management strategy for SSRI-induced xerostomia in the same study.

A separate systematic review associated with the World Workshop of Oral Medicine found 106 medications with strong to moderate evidence of salivary gland dysfunction, and an additional 46 with weaker evidence. The medications causing the most salivary dysfunction are not obscure: antidepressants and antihypertensives are among the most commonly prescribed drug classes in the United States. Polypharmacy compounds the problem: taking multiple medications with xerostomia as a side effect produces additive reduction in salivary flow, which is why older adults taking multiple daily medications face dramatically elevated dental caries risk even when their diet and hygiene habits have not changed.

Medications That Commonly Reduce Salivary Flow

  • Antidepressants: TCAs (amitriptyline: 30-50% xerostomia prevalence), SSRIs (paroxetine: 20-40%), SNRIs. Among the most prescribed drug classes in the US.
  • Antihistamines: First-generation (diphenhydramine, chlorpheniramine) have strongest anticholinergic effect. Second-generation (loratadine, cetirizine) somewhat less but still a factor.
  • Antihypertensives: ACE inhibitors, beta-blockers, calcium channel blockers. Blood pressure medications are among the most widely prescribed drugs in adults over 50.
  • Diuretics: Reduce total body fluid, including salivary output.
  • GLP-1 receptor agonists: Semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), liraglutide (Victoza). ADA lists as a xerostomia-associated drug class. Mechanism may be indirect (reduced food intake, altered fluid intake patterns) rather than direct glandular effect.
  • Muscle relaxants, decongestants, pain medications: Multiple classes with anticholinergic or direct xerogenic effects.
  • Polypharmacy risk: Taking 5+ medications simultaneously with age over 71 = 9.68x higher odds of xerostomia (Frontiers in Oral Health 2026)

Never stop or alter medications to manage dry mouth without consulting your prescribing physician. If you suspect medication-induced xerostomia, discuss with both your physician and dentist.

GLP-1 Agonists and Oral Health

GLP-1 receptor agonists (semaglutide, dulaglutide, liraglutide, and others) have become widely prescribed for type 2 diabetes and weight management, with approximately 1 in 8 Americans reporting GLP-1 use as of 2024 data. The ADA now includes GLP-1 agonists in its list of medication classes associated with xerostomia.

The mechanism differs from the classic anticholinergic pathway. GLP-1 agonists slow gastric emptying and alter appetite signaling, which can reduce food and fluid intake. Less eating means less masticatory stimulation of salivary flow. Reduced fluid intake contributes to lower total body hydration and reduced salivary output. Some GLP-1 users also experience nausea and vomiting, which can alter oral acid exposure. A 2025 study found GLP-1 users may consume insufficient calcium, vitamin C, and vitamin D, nutrients essential for enamel health, as a consequence of reduced appetite and dietary intake.

Whether GLP-1 medications cause dry mouth through a direct glandular mechanism is not yet established: dry mouth is not listed as a confirmed common side effect in the FDA prescribing information for semaglutide, and the clinical trials did not identify it as statistically significant. What is established is that the behavioral and physiological consequences of GLP-1 use (reduced eating, reduced fluid intake, altered meal patterns, reduced masticatory stimulus) all reduce salivary flow indirectly. For GLP-1 users who notice oral health changes, the mechanistic case for using chewing gum to stimulate saliva between meals is particularly strong: it replaces the masticatory salivary stimulus that reduced food intake has removed.

Mouth Breathing

Mouth breathing deserves a specific mention as a saliva-depleting habit that receives less attention than medication-induced xerostomia but affects a significant portion of the population, including many who are unaware of it. During mouth breathing, airflow over the oral cavity accelerates evaporation of saliva from tooth surfaces and oral mucosa. The mechanical drying effect is direct and continuous.

Habitual mouth breathers show consistently higher rates of caries, gingival inflammation, and xerostomia symptoms than nasal breathers across multiple studies. Nighttime mouth breathing is particularly relevant because it occurs during the period of lowest resting salivary flow, compounding the overnight vulnerability window. For habitual mouth breathers, interventions that address the underlying cause (nasal obstruction, deviated septum, enlarged adenoids, or simply habitual pattern) have significant oral health implications beyond the more obvious effects on sleep quality and facial development.

What Happens to Teeth When Saliva Is Low

Xerostomia-induced dental caries has a characteristic pattern that differs from cavities developing in people with normal salivary flow. Rather than the typical interproximal (between teeth) or occlusal (biting surface) caries seen in people with dietary sugar excess, xerostomia-induced caries typically appears at the cervical margin (gumline), on exposed root surfaces, and on incisal edges. These are areas normally well-protected by salivary flow and pellicle. When protection is removed, they become vulnerable.

The progression can be rapid. People who develop xerostomia after radiation therapy to the head and neck (which permanently damages salivary glands) experience what dentists call "radiation caries": within months of treatment, previously healthy mouths develop widespread, rapidly progressing decay. This extreme case illustrates the degree to which saliva is responsible for dental stability under normal conditions. Most medication-induced xerostomia is less severe than radiation damage, but it operates through the same mechanism at a lower intensity over a longer timeframe.

Beyond caries, low salivary flow increases the risk of oral candidiasis (fungal infection), difficulty swallowing (dysphagia), altered taste perception, oral mucosal damage from reduced lubrication, and difficulty wearing dentures (which rely on salivary lubrication for retention and comfort).

What Changes When Salivary Flow Is Low Normal Saliva vs. Low Saliva: What Changes Sources: ADA Xerostomia guidance; Merck Manual 2024; CDHO; PMC Novel Impacts of Saliva Normal Salivary Flow Low Salivary Flow (Xerostomia) pH recovery after meals 20-40 min; full recovery Slower; may be incomplete Enamel remineralization Active; Ca²⁺/PO₄ supersaturated Reduced; minerals less available Pellicle protection Continuous protein film Thinner, less protective Cariogenic bacteria Suppressed by IgA, peroxidase Increased relative advantage Food/acid clearance Rapid; short exposure windows Slow; extended acid contact Caries pattern Typical interproximal/occlusal Cervical, root surface, incisal edges

How to Stimulate Saliva and Support What It Does

Salivary flow responds to stimulation. The two primary stimuli are masticatory (chewing) and gustatory (taste). Either stimulus, or both together, signals the salivary glands through the parasympathetic nervous system to increase output. This is why chewing gum is the most broadly applicable intervention for dry mouth: it provides mechanical chewing stimulus continuously for as long as the gum is chewed, at a level above what resting salivation provides, without requiring food intake.

The ADA endorses sugar-free gum specifically for this mechanism, and it is recommended in clinical guidance for multiple xerostomia-inducing conditions. The 2025 European Psychiatry study on psychiatric medication-induced xerostomia cited sugar-free chewing gum as a management strategy specifically for SSRI users. The ADA's formal guidance on xerostomia lists chewing sugarless gum and sucking sugarless mints as first-line self-care approaches for managing oral dryness.

The masticatory reflex stimulates salivary flow to 10 to 12 times the resting rate with chewing, significantly amplifying all five protective functions simultaneously. Acid buffering improves as bicarbonate-rich stimulated saliva neutralizes residual acid. Mineral delivery improves as higher volumes of calcium- and phosphate-saturated saliva reach tooth surfaces. Antibacterial proteins reach higher concentrations in stimulated versus resting saliva. Clearance accelerates as the total volume of saliva flowing over teeth increases.

For people on xerostomia-inducing medications, the practical protocol is straightforward: chew sugar-free gum after every meal and between meals if oral dryness is noticeable. This directly replaces the masticatory salivary stimulus that medications have partially removed. Staying well hydrated supports overall salivary volume. Avoiding caffeine and alcohol (both of which have diuretic effects that reduce salivary output) reduces additional depletion. Breathing through the nose rather than the mouth eliminates the evaporative drying effect of oral airflow.

Functional gum with nano-HAp adds a mineral delivery component that complements salivary mineral delivery: nano-hydroxyapatite particles deposit the same calcium phosphate mineral that saliva delivers, directly to enamel surfaces, at a concentration that exceeds what saliva alone provides. This is particularly relevant for people with reduced salivary flow whose saliva may be below the supersaturation threshold needed for efficient remineralization. For the full mechanism of nano-HAp in enamel support, see our article on what nano-hydroxyapatite is. For how the ADA specifically frames the chewing gum recommendation, see our article on what the ADA says about chewing gum. And for the Stephan curve context of why post-meal timing matters, see our article on the Stephan curve.

How to Support Salivary Function: The Practical Hierarchy

  • Chew sugar-free gum after meals (10-20 min): Stimulates masticatory salivary reflex to 10-12x resting rate. First-line self-care recommendation for xerostomia from ADA and 2025 European Psychiatry review. Works regardless of the cause of reduced salivary flow.
  • Stay hydrated: Total body hydration directly supports salivary volume. Aim for adequate daily fluid intake; more if taking diuretic medications.
  • Breathe through your nose: Eliminates oral airflow that accelerates salivary evaporation. For chronic mouth breathers, addressing the underlying obstruction (allergies, structural) has direct oral health benefit.
  • Limit caffeine and alcohol: Both have diuretic effects that reduce total body hydration and salivary output. Even moderate habitual intake can compound medication-induced xerostomia.
  • Avoid tobacco: Smoking reduces salivary flow and alters salivary composition, reducing protective protein concentrations.
  • Tell your dentist what you take: Medication history is directly relevant to dental caries risk assessment. Patients on xerostomia-inducing medications may need more frequent professional cleanings and fluoride applications.
  • Nano-HAp functional gum: Supplements the mineral delivery function of reduced saliva by delivering hydroxyapatite directly to enamel surfaces, compensating for lower Ca²⁺/PO₄ availability from insufficient salivary flow.

Frequently Asked Questions

What does saliva actually do for your teeth?

Saliva performs five core protective functions simultaneously: acid buffering (neutralizing post-meal lactic acid through its bicarbonate system), mineral delivery (maintaining calcium and phosphate supersaturation for enamel remineralization), protective pellicle formation (a protein film on enamel that limits acid penetration), antibacterial defense (secretory IgA, peroxidase, and histatins that suppress cariogenic bacteria), and mechanical clearance (physically removing food debris and bacteria from tooth surfaces). All five depend on adequate salivary flow. When flow drops, all five degrade at once.

How common is dry mouth?

Xerostomia affects at least 20% of the general adult population. Prevalence rises to up to 30% in women and up to 50% in adults over 65 (CDHO). More than 500 medications list xerostomia as a side effect, and the ADA identifies antihistamines, antihypertensives, antidepressants, diuretics, GLP-1 agonists, and muscle relaxants as major contributing drug classes. Adults taking five or more medications simultaneously combined with age over 71 face 9.68 times higher odds of xerostomia than the general population, according to a 2026 Frontiers in Oral Health register-based study.

Why does dry mouth cause cavities?

When salivary flow decreases, all five protective saliva functions reduce simultaneously. Acid from bacterial fermentation of food residue takes longer to neutralize, so enamel spends more time below pH 5.5 after each meal. Mineral delivery to enamel surfaces decreases, reducing remineralization capacity. The protective pellicle becomes thinner. Antibacterial proteins become less concentrated, giving cariogenic bacteria a relative advantage. Food debris and bacteria clear more slowly. The combined result is dramatically higher caries risk and a characteristic pattern of decay at the gumline, root surfaces, and incisal edges rather than the typical interproximal pattern.

Do GLP-1 medications like Ozempic cause dry mouth?

Dry mouth is not confirmed as a direct pharmacological effect of GLP-1 medications in FDA prescribing information, and the pivotal clinical trials did not identify it as a statistically significant adverse event. However, the ADA now includes GLP-1 agonists in its list of xerostomia-associated drug classes. The most plausible mechanism is indirect: GLP-1 medications reduce appetite, food intake, and eating frequency, which reduces the masticatory stimulus for salivary flow. Reduced fluid intake from decreased appetite compounds this. A 2025 study also found GLP-1 users may consume insufficient calcium, vitamin C, and vitamin D. For GLP-1 users experiencing oral dryness, chewing sugar-free gum between meals directly replaces the lost masticatory salivary stimulus.

Is chewing gum actually helpful for dry mouth?

Yes, and it is specifically recommended for this purpose. The ADA's Xerostomia guidance lists chewing sugarless gum as a first-line self-care step for oral dryness. A 2025 European Psychiatry study on psychiatric medication-induced xerostomia cited sugar-free chewing gum as a management strategy for SSRI users specifically. The mechanism is direct: chewing stimulates the masticatory salivary reflex, increasing flow to 10 to 12 times the resting rate, which activates all five protective salivary functions simultaneously. This works regardless of whether dry mouth is caused by medication, aging, mouth breathing, or dehydration.

What time of day is saliva at its lowest?

Salivary flow follows a circadian rhythm with its lowest point overnight during sleep. Resting salivary flow at night can drop to near zero in some individuals. This is why the morning oral environment is more vulnerable to acid challenge than the afternoon, why breakfast should be followed by careful oral hygiene or sugar-free gum, and why overnight is the period of greatest risk for people with xerostomia. Mouth breathing during sleep compounds this further by accelerating salivary evaporation during the already lowest-flow period.

Bottom Line

Saliva is not a passive lubricant. It is a precision biological defense system that neutralizes acid, delivers enamel mineral, forms a protective protein barrier, suppresses cariogenic bacteria, and clears food residue from teeth. All five functions operate continuously, all five depend on adequate flow, and all five degrade simultaneously when flow falls. At least 20% of the adult population has clinically significant dry mouth, rising to half of adults over 65. More than 500 medications reduce salivary flow, including the most commonly prescribed drug classes in the US. GLP-1 agonists, now used by approximately 1 in 8 Americans, reduce the masticatory stimulus for salivary production through reduced eating frequency. Mouth breathing depletes saliva during the already-lowest overnight period.

The most accessible intervention for any of these scenarios is also the one with the strongest evidence base: chewing sugar-free gum stimulates salivary flow to 10 to 12 times the resting rate through the masticatory reflex, activating the full protective function set. Functional gum with nano-HAp goes further by supplementing the mineral delivery function that reduced saliva may no longer provide adequately, depositing hydroxyapatite directly to enamel surfaces at the moment they're most receptive to mineral redeposition. The case for using gum as an oral health tool is, at its core, a case for understanding what saliva does and what happens when there isn't enough of it.

Try Dentagum: Stimulate Saliva, Support Enamel

Research Summary

This article draws on saliva composition literature, xerostomia epidemiology, medication-induced dry mouth research, and GLP-1 oral health data. Key sources include: Frontiers in Oral Health 2025 (saliva composition: 99% water; bicarbonate system primary buffer; pH maintained 6.8-7.8; calcium, phosphate, bicarbonate, fluoride electrolytes; statherin, mucins, histatins, proline-rich proteins functions); NIDCR, Developing Salivary Components (Ca²⁺/PO₄ facilitates remineralization; 99.5% water with 0.5% responsible for all functions); PMC Novel Impacts of Saliva 2021 (PMC8669010): pH regulation 6.8-7.8; acquired enamel pellicle; statherin binds Ca/P for supersaturation; sIgA antibacterial; PMC Remineralization of Enamel from Saliva 2024 (PMC11592461): natural remineralization of erosive and initial carious lesions; salivary proteins modulate rate; J Prosthet Dent 2001 (salivary composition; statherin; four functional groupings confirmed); IntechOpen Functions of Saliva (three buffer systems; bicarbonate primary in stimulated saliva; phosphate in unstimulated); J Dent Panacea 2025 (urea buffer; carbonic acid/bicarbonate; phosphate; protein system; peroxidase/sialoperoxidase; histatins antifungal; cystatins; statherin; proline-rich proteins); CDHO Xerostomia factsheet (prevalence: at least 20% general population; up to 30% women; up to 50% adults 65+; 500+ medications cause xerostomia); ADA Xerostomia guidance (antihistamines, antihypertensives, decongestants, pain meds, diuretics, muscle relaxants, GLP-1 agonists, antidepressants; 30% of adults 65+; 40% of adults 80+; 106 medications strong-moderate evidence; 46 medications weak evidence; xerostomia-induced caries: cervical, root, crown margins); Frontiers in Oral Health 2026 register-based study (polypharmacy 5+ meds + age 71+: 9.68x higher odds xerostomia); European Psychiatry 2025 (PMC12437780): amitriptyline 30-50%, paroxetine 20-40%, anticholinergics 20-65% xerostomia prevalence; sugar-free gum recommended for SSRIs; Wellnesspulse 2025 / ADA GLP-1 guidance: 1 in 8 Americans used GLP-1; ADA includes GLP-1 in xerostomia drug classes; 2025 study: GLP-1 users may have insufficient Ca/vit C/vit D; Fella Health 2025: semaglutide dry mouth not confirmed as direct pharmacological effect; indirect mechanisms through reduced eating/fluid intake; ADA Chewing Gum (10-12x salivary flow; 20 min after meals; 7 clinical trials; first-line xerostomia management: chewing sugarless gum). All Dentagum ingredient statistics from ingredient-level published research; not Dentagum product trial claims.

References

  1. Enax J et al. The Remineralization of Enamel from Saliva: A Chemical Perspective. PMC. PMC11592461. Published November 2024. [Natural remineralization of erosive lesions and initial carious lesions from saliva Ca/P deposition; salivary proteins modulate rate to prevent overshooting]
  2. Novel Impacts of Saliva with regard to Oral Health. PMC. PMC8669010. 2021. [Saliva maintains pH 6.8-7.8 via bicarbonate and phosphate; statherin binds Ca/PO₄ for supersaturation; acquired enamel pellicle formation; sIgA most abundant antibody in saliva]
  3. Farooq I, Bugshan A. The role of salivary contents and modern technologies in the remineralization of dental enamel: a narrative review. F1000Research. PMC7076334. 2020. [Three buffer systems: carbonic acid/bicarbonate (most important in stimulated saliva), phosphate (unstimulated), protein system; statherin, proline-rich proteins, histatins; Ca/P supersaturation mechanism]
  4. Dawes C. A review of saliva: Normal composition, flow, and function. J Prosthet Dent. 2001. [Statherin stabilizes Ca/P; four functional groupings: buffering, cleansing, antisolubility/remineralization, antibacterial; supersaturation critical to remineralization]
  5. Abdelghany MHA et al. Saliva and caries protection. EC Dental Science. [Salivary bicarbonate/carbonate system responsible for rapid acid neutralization; statherins produce Ca/P supersaturation state; sialoperoxidase produces hypothiocyanate antibacterial; IgA, IgG, IgM; cystatins control proteolytic activity]
  6. Jain V et al. An insight into the science behind saliva and its crucial role in oral health. J Dent Panacea. July 2025. [Three buffer systems; carbonic acid/bicarbonate primary in stimulated; phosphate in unstimulated; urea/ammonia buffer; proline-rich proteins; statherin; histatins (antifungal)]
  7. Functions of Saliva. IntechOpen. 2019. [Four functional groupings; bicarbonate/phosphate/urea for pH modulation; mucins for cleansing; Ca/P/protein as antisolubility factor; immunoglobulins/enzymes for antibacterial action]
  8. CDHO. Xerostomia factsheet. [Prevalence: at least 20% general population; up to 30% females; up to 50% elderly; 500+ medications cause xerostomia; drug-induced most common cause in elderly; self-care: sugarless gum]
  9. ADA. Xerostomia (Dry Mouth). Oral Health Topics. ada.org. [Antihistamines, antihypertensives, decongestants, pain meds, diuretics, muscle relaxants, GLP-1 agonists, antidepressants listed; affects 30% adults 65+, 40% adults 80+; 106 medications strong-moderate evidence; 46 weak evidence; xerostomia-induced caries at cervical, root, crown margin locations; twice as likely in patients taking daily medications]
  10. Adolfsson A et al. Xerostomia in primary care: a register-based study of prevalence, medication categories, and associated risk factors. Frontiers in Oral Health. 2026. [Polypharmacy 5+ meds + age 71+: 9.68x higher odds xerostomia; metabolic, nervous system, cardiovascular medications most associated; females 73.08% of cases]
  11. Maldonado-Puebla RA, Murugappan M, Carr B. Xerostomia Induced by Psychiatric Medications: Prevalence, Impact, and Management. European Psychiatry. PMC12437780. Published August 2025. [Amitriptyline 30-50%; paroxetine 20-40%; anticholinergics 20-65% xerostomia prevalence; sugar-free chewing gum specifically recommended for SSRI-induced xerostomia]
  12. Wellnesspulse. Ozempic Mouth: How Do GLP-1s Affect Oral Health? August 2025. [1 in 8 Americans used GLP-1 as of 2024; ADA includes GLP-1 in xerostomia drug list; 2025 study: insufficient Ca, vitamin C, vitamin D in GLP-1 users; dry mouth, bad breath, tooth decay reported by patients]
  13. Fella Health. Does Semaglutide Give You Dry Mouth? October 2025. [Dry mouth not confirmed as direct pharmacological effect in FDA prescribing information; SUSTAIN and STEP trials did not identify as statistically significant; indirect pathways: reduced food intake, reduced fluid intake, altered eating patterns; case series 2023: three patients with severe dry mouth on semaglutide]
  14. Merck Manual Professional Edition. Xerostomia. Updated January 2024. [Common in older adults ~20%; long-standing xerostomia causes severe tooth decay and oral candidiasis; reduces oral pH and increases bacterial growth]
  15. StatPearls NCBI. Xerostomia. 2023. [Mouth breathing listed as a cause; 500+ medications; anticholinergic mechanism; drug classes with 10%+ xerostomia incidence]
  16. American Dental Association. Chewing Gum. Oral Health Topics. ada.org. [Unstimulated flow 0.3-0.4 mL/min; chewing base stimulates 10-12x resting rate; 7 clinical trials confirming caries reduction; first-line self-care for xerostomia: chew sugarless gum]